Key result
Patients with atrial fibrillation and type 2 diabetes in the highest SIRI tertile had an 86% increased risk of in-hospital all-cause mortality (HR 1.863) compared to the lowest tertile.
Why the study?
Systemic inflammation affects diabetes and cardiovascular prognosis, but the prognostic significance of the system inflammation response index in patients with both AF and T2DM was unknown.
Does an elevated System Inflammation Response Index (SIRI) predict mortality in patients with atrial fibrillation and type 2 diabetes mellitus?
Observational (n=2,054)
No
Does an elevated System Inflammation Response Index (SIRI) predict mortality in patients with atrial fibrillation and type 2 diabetes mellitus?
Elevated System Inflammation Response Index (SIRI) is an independent predictor of in-hospital and 1-year mortality in patients with concurrent atrial fibrillation and type 2 diabetes mellitus.
Answers are grounded in this paper and cite their sources.
May aid in-hospital risk stratification in AF with diabetes; leaves open whether SIRI improves existing models.
Systemic inflammation plays a crucial role in the pathogenesis and prognosis of diabetes and cardiovascular diseases. System inflammation response index (SIRI), is an emerging biomarker designed to assess the extent of systemic inflammation. We aimed to delineate the prognostic significance of SIRI in patients with both AF and type 2 diabetes mellitus (T2DM). Utilizing the Medical Information Mart for Intensive Care IV (MIMIC-IV) (v2.2) repository, subjects divided into three groups based on the SIRI index. The primary endpoint of our study was all-cause mortality during hospitalization, with one-year mortality serving as the secondary endpoint. A cohort of 2054 AF and T2DM patients participated. COX regression analysis revealed elevated SIRI levels as an independent risk factor for both in-hospital and 1-year mortality. 192 patients died during hospitalization, and 265 died during the follow-up of 1 year. When treating the SIRI as a continuous variable, a higher SIRI was significantly associated with increased all-cause mortality both in-hospital [hazard ratio (HR) 1.015, 95%CI 1.010-1.020, P = 0.015] and 1-year (HR 1. 016, 95%CI 1.008-1.015, P = 0.012). Additionally, compared to patients with the lowest tertiles of SIRI, those with the highest tertiles of SIRI possessed significantly higher all-cause mortality both in-hospital and 1-year after multivariable adjustment, and this relationship remained pronounced in AF and T2DM patients [in-hospital mortality (HR: 1.863, 95% CI 1.189-2.918, P = 0.007); one-year mortality (HR: 2.143, 95% CI 1.621-2.831, P < 0.001)]. Our RCS analyses indicated a pronounced linear association between SIRI and mortality in T2DM (p-value for non-linear < 0.001). In AF patients with T2DM, high SIRI is an independent predictor of poor survival and may be helpful for patient's risk stratification.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) conducted an observational in Atrial fibrillation and type 2 diabetes mellitus (n=2,054). Highest tertile of System Inflammation Response Index (>5.701) vs. Lowest tertile of System Inflammation Response Index (<2.591) was evaluated on All-cause mortality during hospitalization (HR 1.863, 95% CI 1.189-2.918, p=0.007). Patients with atrial fibrillation and type 2 diabetes in the highest SIRI tertile had an 86% increased risk of in-hospital all-cause mortality (HR 1.863) compared to the lowest tertile.
Synapse has enriched 10 related papers. Consider them for comparative context: